BRCA1 and cancer: Recent studies show that BRCA1-deficient fibroblasts treated with uveal melanoma-derived and colorectal cancer-derived EVs transfer malignant traits to target cells, and the authors suggest that BRCA1 activity is necessary to prevent the detrimental effects of cancer-derived EVs in non-cancer cells [155,156].